Peter Hasapis
Internal Medicine · New Canaan, CTNPI 1720154354
Payments from drug & device makers
Across 87 payments — averaging $20.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exact Sciences$287
- Astellas Pharma US Inc$197
- AstraZeneca$147
- Novo Nordisk$126
- Boehringer Ingelheim$105
- Kaleo, Inc.$105
- plus $845 from 25 others
What the payments were for
- Food & beverage$1,71995%
- Education$955%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exact Sciences | 12 | $287 |
| Astellas Pharma US Inc | 7 | $197 |
| AstraZeneca | 9 | $147 |
| Novo Nordisk | 5 | $126 |
| Boehringer Ingelheim | 5 | $105 |
| Kaleo, Inc. | 5 | $105 |
| Merck | 5 | $102 |
| Pfizer | 5 | $71 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| Baxter Healthcare | 1 | $50 |
| Johnson & Johnson | 3 | $44 |
| Lilly USA, LLC | 2 | $43 |
| Bayer | 2 | $42 |
| Amgen | 2 | $42 |
| Sanofi Pasteur Inc. | 2 | $39 |
| AbbVie | 2 | $39 |
| Novartis | 2 | $38 |
| Tris Pharma Inc | 2 | $29 |
| Corcept Therapeutics | 1 | $24 |
| Dermira, Inc. | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Ironshore Pharmaceuticals Inc. | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Intra-sana Laboratories | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Genentech USA, Inc. | 1 | $18 |
| Amarin Pharma, Inc. | 1 | $16 |
| Cranial Technologies, Inc | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Neos Therapeutics, LP | 1 | $12 |
How this compares
$1,813 in reported general payments places this provider in the 80th percentile of 2,067 internal medicine providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 84 | $64,145 |
| OzempicSemaglutide | 38 | $36,212 |
| FarxigaDapagliflozin Propanediol | 47 | $32,404 |
| XareltoRivaroxaban | 20 | $23,997 |
| JardianceEmpagliflozin | 23 | $14,934 |
| MyrbetriqMirabegron | 20 | $13,727 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $7,438 |
| BrilintaTicagrelor | 13 | $5,550 |
| Methylphenidate Er (La)Methylphenidate Hcl | 12 | $2,703 |
| Atorvastatin Calcium | 173 | $1,653 |
| Galantamine ErGalantamine Hbr | 13 | $1,396 |
| Tamsulosin Hcl | 32 | $1,088 |
| Rosuvastatin Calcium | 60 | $989 |
| Levothyroxine Sodium | 84 | $961 |
| Valsartan | 42 | $951 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $71 | $64,14584 claims |
| AstraZenecaFarxiga, Brilinta | $147 | $37,95460 claims |
| Novo NordiskOzempic | $126 | $36,21238 claims |
| Johnson & JohnsonXarelto | $44 | $23,99720 claims |
| Boehringer IngelheimJardiance | $105 | $14,93423 claims |
| Astellas Pharma US IncMyrbetriq | $197 | $13,72720 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,067 internal medicine providers in Connecticut.
Other internal medicine in New Canaan
- Joseph SouferWaterbury$21.5M
- David RadinStamford$7M
- Steven RyderWestport$3.9M
- Nancy BrownNew Haven$2.8M
- Charles MontanoCromwell$2.8M
- Arthur DecillisMadison$1M
- Michelle MallitzTrumbull$971K
- Allen HellerWoodbridge$758K
- Gary BlickNorwalk$717K
- Margaret ChusteckaHamden$652K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.